A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinomaWEISS, G. R; MARGOLIN, K. A; HAWKINS, M. J et al.Journal of clinical oncology. 1992, Vol 10, Num 2, pp 275-281, issn 0732-183XArticle

Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinomaGAYNOR, E. R; WEISS, G. R; BAR, M. H et al.Journal of the National Cancer Institute. 1990, Vol 82, Num 17, pp 1397-1402, issn 0027-8874Article

Pathogenesis of pulmonary edema during interleukin-2 therapy : correlation of chest radiographic and clinical findings in 54 patientsSAXON, R. R; KLEIN, J. S; BAR, M. H et al.American journal of roentgenology (1976). 1991, Vol 156, Num 2, pp 281-285, issn 0361-803XConference Paper

Disseminated Pneumocystis carinii infection in a patient with acquired immunodeficiency syndromeGRIMES, M. M; LAPOOK, J. D; BAR, M. H et al.Human pathology. 1987, Vol 18, Num 3, pp 307-308, issn 0046-8177Article